Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-05-19 @ 12:14 AM
Study NCT ID:
NCT00876993
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2009-04-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Sponsor:
Johns Hopkins All Children's Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Central Nervous System Tumors | View |
Keywords: